News

August 2, 2016August 2, 2016

Melanoma Screenings for Atypical Moles Should Include Perianal Area

News

Patients undergoing melanoma screening and surveillance should be examined in the perianal area for melanocytic nevi, or moles, that are associated with atypical nevi elsewhere on the body, according to researchers at ... Read more

July 28, 2016July 28, 2016

Metastatic Melanomas Respond to Immunotherapy Combo in Early Clinical Study

News

The immune-therapy drug ipilimumab together with talimogene laherparepvec, or T-VEC, produced positive results in a Phase 1b clinical trial in patients with metastatic melanomas, who did not respond to other ... Read more

July 26, 2016July 26, 2016

New Compound Against Sun’s UVA Rays Might Improve Sunscreens

News

Developed by United Kingdom researchers, a new compound dubbed “mitoiron claw” can protect cells from UVA radiation in sunlight and might enhance the effects of sunscreen and skin care products that now ... Read more

July 21, 2016July 21, 2016

Immunotherapy Approach to Treat Melanoma Looks Promising, Studies Reveal

News

Blocking immune checkpoints as well as modifying T-cells could treat melanoma according to two new studies conducted by researchers at the Clinical Research Division of the Fred Hutch Cancer Research ... Read more

July 19, 2016July 19, 2016

Researchers Identify How Melanoma Avoids Immune Checkpoints, Potentially Leading to New Therapies

News

Researcher at the University of California, Los Angeles (UCLA) have identified new mechanisms used by melanoma cells to avoid being recognized by the immune system and therefore escape it. This ... Read more

July 14, 2016July 14, 2016

Melanoma Gene Expression Testing Changed Clinical Treatment for Over Half the Patients Tested, Study Shows

News

A design impact study of Castle Biosciences‘ DecisionDx-Melanoma gene expression profile (GEP) test for cutaneous melanoma (CM) was recently published in the journal Current Medical Research and Opinion. The test by Texas-based ... Read more

July 12, 2016July 12, 2016

Easier Access to Melanoma Screenings Doesn’t Result in Excessive Treatment, Community Study Reports

News

Results from a large-scale melanoma screening conducted in Pennsylvania indicate that, overall, the practice complies with the medical maxim: “first do no harm.” The numbers show that melanoma screenings did ... Read more

July 7, 2016July 7, 2016

Medical Cannabis Therapy for Melanoma Being Developed at University of Canberra

News

The University of Canberra has signed a $1 million (Australian dollars) collaboration with Cann Pharmaceutical — a joint venture between better Medical Grade Cannabis of Israel and Australia’s Curus Medical — to create a ... Read more

July 5, 2016July 5, 2016

Malignant Melanoma Rates Up 155% Among Older Adults in UK Since 1990s

News

Cancer Research UK released demographic data this week showing that malignant melanoma rates in the U.K. have more than doubled among people ages 55 and older since the mid-1990s, and are also ... Read more

June 30, 2016June 30, 2016

Melanoma Skin Check Partners Help Patients Identify New Cancers

News

A recent clinical trial proved that skin-check partners of melanoma patients can successfully assist with skin self-examinations by recognizing new melanomas and increasing early detection of the cancer. The study, “Early Detection of New Melanomas ... Read more

June 28, 2016June 28, 2016

Melanoma Identified by Cognitive Technology Closer with IBM, Australian Research

News

IBM Research in Australia will conduct new research with Melanoma Institute Australia to help further a plan to use cognitive technology for melanoma identification. The project builds on IBM’s pre-existing agreement with MoleMap – a company that ... Read more

June 23, 2016June 23, 2016

Combination Immunotherapy for Melanoma Receives NICE Approval

News

The National Institute for Health and Care Excellence (NICE) has approved the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) for patients in England and Wales with metastatic melanoma. Ipilumumab targets the CTLA-4 molecule found ... Read more

June 16, 2016June 16, 2016

Early Studies Show Ricolinostat Boosts Immunotherapy Used to Treat Melanoma

News

Acetylon Pharmaceuticals announced the publication of two abstracts describing preclinical trials that demonstrated the potential of ricolinostat (ACY-1215), a HDAC6 inhibitor, to augment immunotherapies used to treat melanoma, and plans to start clinical testing in ... Read more

June 14, 2016June 14, 2016

Brake Release in Natural Killer (NK) Cells Could Boost Cancer Defenses

News

While many scientists have focused on how to make adaptive immune T-cells better fight cancer, Drs. Sandra Nicholson and Nicholas Huntington looked to a subtype of innate immune cells specialized in eliminating ... Read more

June 9, 2016June 9, 2016

Radiation, Immunotherapy Combo a Promising Approach Against Melanoma

News

Researchers at Loyola University Chicago Stritch School of Medicine have found that the combination of new immunotherapies with radiation therapy offers a promising therapeutic approach for melanoma patients. The study, “The integration ... Read more

June 7, 2016June 7, 2016

New Uveal Melanoma Clinical Data Revealed at ASCO 2016

News

Castle Biosciences, a manufacturer of molecular diagnostics for cancer treatments, recently revealed current clinical data on a new test designed to predict metastasis in patients with uveal melanoma. The information about ... Read more

June 2, 2016June 2, 2016

Researchers Identify Cause for Merkel Skin Cancer, FDA Approved Drug to Stop It

News, Skin Cancer

Researchers from the Perelman School of Medicine at the University of Pennsylvania have uncovered a skin cell  predominantly infected by the Merkel cell polyomavirus, which can cause Merkel cell carcinoma ... Read more

May 26, 2016May 26, 2016

EC Approves Immuno-Oncology Combination of Opdivo and Yervoy Regimen for Advanced Melanoma

News

The European Commission (EC) has approved  the combination of Opdivo (nivolumab) and Yervoy (ipilimumab) in the treatment of patients diagnosed with BRAF V600 wild-type unresectable or metastatic melanoma. This is the first and only combination treatment of two ... Read more

May 25, 2016May 25, 2016

2 Metastatic Melanoma Patients Reported to Live Disease-free for Years After Immunotherapy

News

A case study reported on two patients with advanced melanoma that had spread to the liver, who experienced progression-free long-term survival — of 4.5 and 12 years — following removal of ... Read more

May 24, 2016May 24, 2016

Pembrolizumab Thwarts Advanced Melanoma, Study Reports

News

In the largest study ever performed in patients with advanced melanoma, researchers showed that the immunotherapy medication pembrolizumab (Keytruda) put the cancer in regression with treatment effects lasting up to three years. ... Read more